Filtered By:
Infectious Disease: Hepatitis C
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 11826 results found since Jan 2013.
Clinical features and diagnostic challenges of mpox (monkeypox) outbreak in Malta: a retrospective cohort study
CONCLUSION: The results shed light on unique challenges faced by the local sexual health clinic and call for more resources in response to the global emerging of infectious diseases.PMID:37592818 | DOI:10.1111/ijd.16811
Source: Herpes - August 18, 2023 Category: Infectious Diseases Authors: Matthew Valentino Katya Muscat Alexandra Gauci Donia Gamoudi Valeska Padovese Source Type: research
Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6
Obstet Gynecol. 2023 Sep 1;142(3):745-759. doi: 10.1097/AOG.0000000000005300.ABSTRACTPURPOSE: The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION: Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS: This guideline was developed using an a ...
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Source Type: research
Risk Factors for Perinatal Transmission of Hepatitis C Virus
CONCLUSION: Perinatal transmission of HCV infection was limited to viremic individuals. High viral loads and antepartum bleeding were associated with perinatal transmission.PMID:37590978 | PMC:PMC10437102 | DOI:10.1097/AOG.0000000000005306
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Authors: Mona Prasad George R Saade Rebecca G Clifton Grecio J Sandoval Brenna L Hughes Uma M Reddy Anna Bartholomew Ashley Salazar Edward K Chien Alan T N Tita John M Thorp Torri D Metz Ronald J Wapner Vishakha Sabharwal Hyagriv N Simhan Geeta K Swamy Kent D Heyb Source Type: research
Apolipoprotein E and viral infection: Risks and Mechanisms
Mol Ther Nucleic Acids. 2023 Jul 28;33:529-542. doi: 10.1016/j.omtn.2023.07.031. eCollection 2023 Sep 12.ABSTRACTApolipoprotein E (ApoE) is a multifunctional protein critical for lipid metabolism and cholesterol homeostasis. In addition to being a well known genetic determinant of both neurodegenerative and cardiovascular diseases, ApoE is frequently involved in various viral infection-related diseases. Human ApoE protein is functionally polymorphic with three isoforms, namely, ApoE2, ApoE3, and ApoE4, with markedly altered protein structures and functions. ApoE4 is associated with increased susceptibility to infection wit...
Source: Herpes - August 17, 2023 Category: Infectious Diseases Authors: Feng Chen Qiongwei Ke Wenyan Wei Lili Cui Yan Wang Source Type: research
Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6
Obstet Gynecol. 2023 Sep 1;142(3):745-759. doi: 10.1097/AOG.0000000000005300.ABSTRACTPURPOSE: The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION: Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS: This guideline was developed using an a ...
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Source Type: research
Risk Factors for Perinatal Transmission of Hepatitis C Virus
CONCLUSION: Perinatal transmission of HCV infection was limited to viremic individuals. High viral loads and antepartum bleeding were associated with perinatal transmission.PMID:37590978 | PMC:PMC10437102 | DOI:10.1097/AOG.0000000000005306
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Authors: Mona Prasad George R Saade Rebecca G Clifton Grecio J Sandoval Brenna L Hughes Uma M Reddy Anna Bartholomew Ashley Salazar Edward K Chien Alan T N Tita John M Thorp Torri D Metz Ronald J Wapner Vishakha Sabharwal Hyagriv N Simhan Geeta K Swamy Kent D Heyb Source Type: research
Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6
Obstet Gynecol. 2023 Sep 1;142(3):745-759. doi: 10.1097/AOG.0000000000005300.ABSTRACTPURPOSE: The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION: Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS: This guideline was developed using an a ...
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Source Type: research
Risk Factors for Perinatal Transmission of Hepatitis C Virus
CONCLUSION: Perinatal transmission of HCV infection was limited to viremic individuals. High viral loads and antepartum bleeding were associated with perinatal transmission.PMID:37590978 | PMC:PMC10437102 | DOI:10.1097/AOG.0000000000005306
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Authors: Mona Prasad George R Saade Rebecca G Clifton Grecio J Sandoval Brenna L Hughes Uma M Reddy Anna Bartholomew Ashley Salazar Edward K Chien Alan T N Tita John M Thorp Torri D Metz Ronald J Wapner Vishakha Sabharwal Hyagriv N Simhan Geeta K Swamy Kent D Heyb Source Type: research
Direct-Acting Antivirals for Hepatitis C and Implication for Community Pharmacy Practice
Curr Pharm Des. 2023 Aug 16. doi: 10.2174/1381612829666230816145931. Online ahead of print.ABSTRACTThe treatment options for hepatitis C have undergone noteworthy advancements since direct-acting antivirals (DAAs) were introduced. The selection of a DAA therapy depends on the patient's genotype, treatment history, concomitant comorbidities, and concurrent medications. Pharmacists have a pivotal role in providing clarification and recommendations in selecting appropriate, individualized DAAs for patients. This commentary aims to (1) provide an overview of DAAs on the market for hepatitis C, and (2) describe the implication ...
Source: Current Pharmaceutical Design - August 16, 2023 Category: Drugs & Pharmacology Authors: Sara McEntee Yifei Liu Tahar Mahmoudi Kathryn Oliver Chad Cadwell Source Type: research
Protein Induced by Vitamin K Absence or Antagonist-II Versus Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
CONCLUSION: This study reveals that PIVKA-II is a promising biomarker for identifying and tracking HCC, exhibiting greater accuracy than AFP. Our findings indicate that PIVKA-II outperforms AFP in detecting HCC across diverse racial groups and sample sizes, as well as in cases of HBV-related, HCV-related, or mixed-etiology HCC.PMID:37575350 | PMC:PMC10416192 | DOI:10.14740/jocmr4951
Source: Clin Med Res - August 14, 2023 Category: Research Authors: Abdallah Kobeissy Nooraldin Merza Alsadiq Al-Hillan Safa Boujemaa Zohaib Ahmed Mohamad Nawras Mohammed Albaaj Dushyant Singh Dahiya Yaseen Alastal Mona Hassan Source Type: research
